Eli Lilly to Acquire Merida Biosciences for Up to $2.875 Billion
Eli Lilly and Company announced a definitive agreement to acquire Merida Biosciences for up to $2.875 billion in cash, incorporating an upfront payment and contingent milestone payments. The transaction targets … Read More